Related Experiment Video
Updated: Oct 1, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism
Tania Fernandez1, Stephanie Amoroso, Shellyann Sharpe
1Laboratory of Cell Regulation and Carcinogenesis, The National Cancer Institute, The National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Transforming growth factor (TGF)-beta is the prototype in a family of secreted proteins that act in autocrine and paracrine pathways to regulate cell development and function. Normal cells typically coexpress TGF-beta receptors and one or more isoforms of TGF-beta, thus the synthesis and secretion of TGF-beta as an inactive latent complex is considered an essential step in regula-ting the activity of this pathway. To determine whether intracellular activation of TGF-beta results in TGF-beta ligand-receptor interactions within the cell, we studied pristane-induced plasma cell tumors (PCTs). We now demonstrate that active TGF-beta1 in the PCT binds to intracellular TGF-beta type II receptor (TbetaRII). Disruption of the expression of TGF-beta1 by antisense TGF-beta1 mRNA restores localization of TbetaRII at the PCT cell surface, indicating a ligand-induced impediment in receptor trafficking. We also show that retroviral expression of a truncated, dominant-negative TbetaRII (dnTbetaRII) effectively competes for intracellular binding of active ligand in the PCT and restores cell surface expression of the endogenous TbetaRII. Analysis of TGF-beta receptor-activated Smad2 suggests the intracellular ligand-receptor complex is not capable of signaling. These data are the first to demonstrate the formation of an intracellular TGF-beta-receptor complex, and define a novel mechanism for modulating the TGF-beta signaling pathway.
Insights
Transforming growth factor-beta (TGF-β) can bind to its receptor intracellularly in plasma cell tumors. This binding impacts receptor trafficking but does not appear to activate downstream signaling pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Biology
Background:
- Transforming growth factor-beta (TGF-β) is a key regulator of cell development and function, acting through autocrine and paracrine pathways.
- TGF-β is secreted as an inactive latent complex, and its regulation is crucial for pathway activity.
- Normal cells express both TGF-β isoforms and their receptors, maintaining controlled signaling.
Purpose of the Study:
- To investigate intracellular TGF-β ligand-receptor interactions within plasma cell tumors (PCTs).
- To determine if active TGF-β1 binds to intracellular TGF-beta type II receptor (TbetaRII) in PCTs.
- To elucidate the impact of intracellular TGF-β-TbetaRII binding on receptor trafficking and signaling.
Main Methods:
- Studied pristane-induced plasma cell tumors (PCTs) to analyze TGF-β signaling.
- Utilized antisense TGF-β1 mRNA to disrupt TGF-β1 expression and observe TbetaRII localization.
- Employed retroviral expression of a dominant-negative TbetaRII (dnTbetaRII) to compete for intracellular ligand binding.
- Analyzed TGF-β receptor-activated Smad2 phosphorylation to assess signaling activation.
Main Results:
- Demonstrated that active TGF-β1 binds to intracellular TbetaRII in PCTs.
- Showed that disrupting TGF-β1 expression restores TbetaRII to the cell surface, indicating ligand-induced trafficking impediment.
- Confirmed that dnTbetaRII competes for intracellular TGF-β1 binding and restores cell surface TbetaRII.
- Found that the intracellular TGF-β-TbetaRII complex does not appear to activate Smad2-mediated signaling.
Conclusions:
- Established the first evidence of an intracellular TGF-β-receptor complex formation.
- Defined a novel mechanism for modulating TGF-β signaling through intracellular interactions.
- Highlighted a potential regulatory pathway impacting receptor trafficking in cancer cells.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...